Literature DB >> 22987652

Development of clinical immunity to malaria in highland areas of low and unstable transmission.

Melissa A Rolfes1, Matthew McCarra, Ng'wena G Magak, Kacey C Ernst, Arlene E Dent, Kim A Lindblade, Chandy C John.   

Abstract

In highland areas of unstable, low malaria transmission, the extent to which immunity to uncomplicated malaria develops with age and intermittent parasite exposure has not been well characterized. We conducted active surveillance for clinical malaria during April 2003-March 2005 in two highland areas of western Kenya (Kapsisiywa and Kipsamoite). In both sites, annual malaria incidence was significantly lower in persons ≥ 15 years of age than in persons < 5 years of age (Kapsisiywa: incidence = 382.9 cases/1,000 persons among persons < 1-4 years of age versus 135.1 cases/1,000 persons among persons ≥ 15 years of age; Kipsamoite: incidence = 233.0 cases/1,000 persons in persons < 1-4 years of age versus 43.3 cases/1,000 persons in persons ≥ 15 years of age). In Kapsisiywa, among persons with malaria, parasite density and axillary body temperature were also significantly lower in persons ≥ 15 years of age than in persons < 5 years of age. Even in highland areas of unstable and low malaria transmission, age is associated with development of clinical immunity to malaria.

Entities:  

Mesh:

Year:  2012        PMID: 22987652      PMCID: PMC3516254          DOI: 10.4269/ajtmh.2012.11-0530

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  39 in total

1.  Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria.

Authors:  Hugh Reyburn; Redempta Mbatia; Chris Drakeley; Jane Bruce; Ilona Carneiro; Raimos Olomi; Jonathan Cox; W M M M Nkya; Martha Lemnge; Brian M Greenwood; Eleanor M Riley
Journal:  JAMA       Date:  2005-03-23       Impact factor: 56.272

2.  Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children.

Authors:  P B Bloland; D A Boriga; T K Ruebush; J B McCormick; J M Roberts; A J Oloo; W Hawley; A Lal; B Nahlen; C C Campbell
Journal:  Am J Trop Med Hyg       Date:  1999-04       Impact factor: 2.345

3.  The effect of altitude on parasite density case definitions for malaria in northeastern Tanzania.

Authors:  Clare I R Chandler; Chris J Drakeley; Hugh Reyburn; Ilona Carneiro
Journal:  Trop Med Int Health       Date:  2006-08       Impact factor: 2.622

Review 4.  Using the entomological inoculation rate to assess the impact of vector control on malaria parasite transmission and elimination.

Authors:  Ayesha M Shaukat; Joel G Breman; F Ellis McKenzie
Journal:  Malar J       Date:  2010-05-12       Impact factor: 2.979

5.  Malaria morbidity among children exposed to low seasonal transmission in Dakar, Senegal and its implications for malaria control in tropical Africa.

Authors:  J F Trape; E Lefebvre-Zante; F Legros; P Druilhe; C Rogier; H Bouganali; G Salem
Journal:  Am J Trop Med Hyg       Date:  1993-06       Impact factor: 2.345

6.  Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area.

Authors:  David M Menge; Kacey C Ernst; John M Vulule; Peter A Zimmerman; Hongfei Guo; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

7.  An estimation of the entomological inoculation rate for Ifakara: a semi-urban area in a region of intense malaria transmission in Tanzania.

Authors:  C Drakeley; D Schellenberg; J Kihonda; C A Sousa; A P Arez; D Lopes; J Lines; H Mshinda; C Lengeler; J Armstrong Schellenberg; M Tanner; P Alonso
Journal:  Trop Med Int Health       Date:  2003-09       Impact factor: 2.622

8.  Topography-derived wetness indices are associated with household-level malaria risk in two communities in the western Kenyan highlands.

Authors:  Justin M Cohen; Kacey C Ernst; Kim A Lindblade; John M Vulule; Chandy C John; Mark L Wilson
Journal:  Malar J       Date:  2008-02-29       Impact factor: 2.979

Review 9.  Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity.

Authors:  Emelda A Okiro; Abdullah Al-Taiar; Hugh Reyburn; Richard Idro; James A Berkley; Robert W Snow
Journal:  Malar J       Date:  2009-01-07       Impact factor: 2.979

10.  The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide.

Authors:  Carlos A Guerra; Priscilla W Gikandi; Andrew J Tatem; Abdisalan M Noor; Dave L Smith; Simon I Hay; Robert W Snow
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

View more
  18 in total

1.  Changes in antigen-specific cytokine and chemokine responses to Plasmodium falciparum antigens in a highland area of Kenya after a prolonged absence of malaria exposure.

Authors:  Lyticia A Ochola; Cyrus Ayieko; Lily Kisia; Ng'wena G Magak; Estela Shabani; Collins Ouma; Chandy C John
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

Review 2.  Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.

Authors:  Johannes Mischlinger; Caroline Rönnberg; Míriam J Álvarez-Martínez; Silja Bühler; Małgorzata Paul; Patricia Schlagenhauf; Eskild Petersen; Michael Ramharter
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

3.  Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.

Authors:  Gregory S Noland; Paul Jansen; John M Vulule; Gregory S Park; Bartholomew N Ondigo; James W Kazura; Ann M Moormann; Chandy C John
Journal:  Acta Trop       Date:  2014-10-24       Impact factor: 3.112

4.  Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu.

Authors:  Akira Kaneko; Luis F Chaves; George Taleo; Morris Kalkoa; Rie Isozumi; Renu Wickremasinghe; Hedvig Perlmann; Satoru Takeo; Takafumi Tsuboi; Shin-ichiro Tachibana; Masatsugu Kimura; Anders Björkman; Marita Troye-Blomberg; Kazuyuki Tanabe; Chris Drakeley
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

5.  Analysis of the spatial and temporal distribution of malaria in an area of Northern Guatemala with seasonal malaria transmission.

Authors:  Lucio Malvisi; Catherine L Troisi; Beatrice J Selwyn
Journal:  Parasitol Res       Date:  2018-06-23       Impact factor: 2.289

Review 6.  Anti-malarial humoral immunity: the long and short of it.

Authors:  Kai J Rogers; Rahul Vijay; Noah S Butler
Journal:  Microbes Infect       Date:  2021-03-05       Impact factor: 2.700

7.  The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya.

Authors:  Lyticia A Ochola; Gideon M Ng'wena; Gregory S Noland; Bartholomew N Ondigo; George Ayodo; Chandy C John
Journal:  J Glob Infect Dis       Date:  2013-10

8.  Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenyan highland sites with differing transmission levels.

Authors:  Elisabeth Baum; Kingsley Badu; Douglas M Molina; Xiaowu Liang; Philip L Felgner; Guiyun Yan
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 9.  Antibody Correlates of Protection from Clinical Plasmodium falciparum Malaria in an Area of Low and Unstable Malaria Transmission.

Authors:  Karen E S Hamre; Bartholomew N Ondigo; James S Hodges; Sheetij Dutta; Michael Theisen; George Ayodo; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2020-10-27       Impact factor: 3.707

10.  Sensitivity of fever for diagnosis of clinical malaria in a Kenyan area of unstable, low malaria transmission.

Authors:  Albino L Mutanda; Priscah Cheruiyot; James S Hodges; George Ayodo; Wilson Odero; Chandy C John
Journal:  Malar J       Date:  2014-04-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.